BIOSTEM TECHNOLOGIES, INC.
Ownership & governance
Executives 5Directors 7Avg age 55Avg tenure 5.3y
JM
Jason Matuszewski
Chief Executive Officer
Since 2019-10-21Profile →
+11
Executives5
Board of directors7
JM
Jason Matuszewski→
Chairman
——
AV
Andrew van Vurst→
Director/Board Member
—Since 2006-07-06
KW
Ken Warrington→
Director/Board Member
—Since 2022-02-28
JU
Jodi Ungrodt→
Director/Board Member
—Since 2026-03-17
MG
Mark Glickman→
Director/Board Member
Age 60Since 2026-06-04
SS
Steven Sonenreich→
Director/Board Member
—Since 2026-06-04
RH
Rayna Lesser Hannaway→
Director/Board Member
—Since 2026-06-04
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Andrew van Vurst | 8.89 % | 1,452,449 |
| Jason Matuszewski | 7.166 % | 1,170,869 |
| Henry van Vurst | 6.693 % | 1,093,579 |
| Michael Dietzen | 6.121 % | 1,000,000 |
| Michael Fortunato | 0.2873 % | 46,936 |
Catalog · 2026-07-09
Registry officers12
| Name | Role | Since | Shares |
|---|---|---|---|
| Andrew van Vurst | Chief Operating Officer | 2006-07-06 | - |
| Brandon Poe | Director of Finance/CFO | 2025-08-13 | - |
| Jason Matuszewski | Chairman | — | - |
| Jason Matuszewski | Chief Executive Officer | 2019-10-21 | - |
| Wendy Weston | Chief Tech/Sci/R&D Officer | 2020-06-30 | - |
| Andrew van Vurst | Director/Board Member | 2006-07-06 | - |
| Jodi Ungrodt | Director/Board Member | 2026-03-17 | - |
| Ken Warrington | Director/Board Member | 2022-02-28 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 7Range 7–7Analysts 1
- Buy 1
Broker actions1
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Zacks Investment Research | Initiated | Buy | 6.4 | 2022-11-07 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.